The Movement of Botulinum Toxin Through the Lateral Gastrocnemius Muscle in Humans: An Expanded Examination

PHASE4TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 15, 2018

Primary Completion Date

September 18, 2019

Study Completion Date

September 18, 2019

Conditions
StrokeMuscle Spasticity
Interventions
DRUG

Botox

THE PROTOCOL DESCRIPTION ATTEMPTED TO OUTLINE A CONTINGINECY PLAN- MOVING TO ONE OF TWO METHODOLOGOIES DPENDING ON PRELIMINARY FINDINGS. UNFORTUNATLEY, OVER 2 YEARS RECRUITMENT WAS GROSSLY INADEQUATE PREVENTING ANY TYPE OF EVEN CURSURY PRELIMINARY DATA ANALYSIS AND FORCING THE EARLY TERMINATION OF THIS STUDY. MICHAEL W. O'DELL, MD

Trial Locations (1)

10065

NewYork Presbyterian Hospital - Weill Cornell Medicine, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER